TCIM
ATNM icon

TIAA CREF Investment Management’s Actinium Pharmaceuticals ATNM Stock Holding History

TIAA CREF Investment Management’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,819
Closed -$304K – 3105
2015
Q2 		$304K Buy
3,819
+185
+5% +$15.8K ﹤0.01% 3068
2015
Q1 		$269K Buy
3,634
+21
+0.6% +$2.5K ﹤0.01% 3027
2014
Q4 		$638K Buy
3,613
+50
+1% +$9.49K ﹤0.01% 2878
2014
Q3 		$716K Buy
3,563
+148
+4% +$29.4K ﹤0.01% 2819
2014
Q2 		$740K Buy
+3,415
New +$1.14M ﹤0.01% 2891

Other funds holding ATNM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

TIAA CREF Investment Management's ATNM Position: Q3 2015 in Review

TIAA CREF Investment Management sold out of Actinium Pharmaceuticals (ATNM) in Q3 2015, closing a stake of 3,819 shares — an estimated $304K sold.

TIAA CREF Investment Management first reported a position in ATNM in Q2 2014 and held it in 5 quarters. The position peaked at $740K in Q2 2014. 27 funds tracked by Wall St. Rank hold ATNM as of Q3 2015.

  • TIAA CREF Investment Management reported no remaining Actinium Pharmaceuticals position as of Q3 2015 after selling out during the quarter.
  • TIAA CREF Investment Management sold 3,819 Actinium Pharmaceuticals shares in Q3 2015, an estimated $304K.
  • TIAA CREF Investment Management first reported a position in Actinium Pharmaceuticals in Q2 2014 and held it in 5 quarters.
  • TIAA CREF Investment Management's Actinium Pharmaceuticals position peaked at $740K in Q2 2014.
  • 27 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q3 2015.

Based on TIAA CREF Investment Management's 13F filing for Q3 2015, filed 13 Nov 2015.